![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Clomiphene citrate (CC) has been widely used for ovulation induction since the 1960s, due to its ease of administration and minimal side-effects. We conducted a retrospective study of 565 women who attended the infertility clinic at a district general hospital (Victoria Hospital, Kirkcaldy) between January 2004 and October 2008. The database was analysed for age, pregnancy rates, type of infertility and pregnancy outcomes. The conception rate with clomiphene citrate was 25%. The drug was well tolerated in 97.5% of women. The miscarriage rate with CC was 4.3%. We believe that these data give useful insights on CC therapy to gynaecologists involved in infertility clinics in a district general hospital setting.
Keywords:
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.